dapsone has been researched along with Giant Cell Arteritis in 21 studies
Giant Cell Arteritis: A systemic autoimmune disorder that typically affects medium and large ARTERIES, usually leading to occlusive granulomatous vasculitis with transmural infiltrate containing multinucleated GIANT CELLS. The TEMPORAL ARTERY is commonly involved. This disorder appears primarily in people over the age of 50. Symptoms include FEVER; FATIGUE; HEADACHE; visual impairment; pain in the jaw and tongue; and aggravation of pain by cold temperatures. (From Adams et al., Principles of Neurology, 6th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Authors describe three cases of agranulocytosis in patients with giant cell (temporal) arterities treated with Dapsone and corticosteroids." | 8.77 | [Agranulocytosis caused by dapsone. Apropos of 3 cases. Review of the literature]. ( Bordessoule, D; Cransac, M; Fourgnaud-Gaillard, S; Liozon, E; Liozon, F; Rousset, H; Vidal, E; Weinbreck, P, 1988) |
| "The authors report 8 cases of Horton's disease and/or polymyalgia rheumatica treated with prednisone with an initially favourable result." | 7.67 | [Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica]. ( Celton, H; Doury, P; Eulry, F; Fabresse, FX; Larroque, P; Pattin, S, 1984) |
| " Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection." | 6.50 | Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014) |
| "Authors describe three cases of agranulocytosis in patients with giant cell (temporal) arterities treated with Dapsone and corticosteroids." | 4.77 | [Agranulocytosis caused by dapsone. Apropos of 3 cases. Review of the literature]. ( Bordessoule, D; Cransac, M; Fourgnaud-Gaillard, S; Liozon, E; Liozon, F; Rousset, H; Vidal, E; Weinbreck, P, 1988) |
| "The authors report 8 cases of Horton's disease and/or polymyalgia rheumatica treated with prednisone with an initially favourable result." | 3.67 | [Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica]. ( Celton, H; Doury, P; Eulry, F; Fabresse, FX; Larroque, P; Pattin, S, 1984) |
| " Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection." | 2.50 | Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014) |
| "Giant cell arteritis is a medium- and large-vessel vasculitis, the most prevalent systemic vasculitis in subjects over age 60." | 2.44 | [Giant cell arteritis]. ( Liozon, E; Ly, K, 2008) |
| " We describe 3 such patients, and our experience in tapering their steroid dosage with the use of dapsone or methotrexate." | 2.39 | Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients. ( Nesher, G; Sonnenblick, M, 1994) |
| "The authors report two cases of Horton's disease and one case of rhizomelic pseudopolyarthritis treated initially with delta-cortisone with a very rapid favourable result." | 1.27 | [Value of dapsone in the treatment of Horton's disease and rhizomelic pseudopolyarthritis]. ( Doury, P; Eulry, F; Masson, C; Maurel, C; Pattin, S; Tabaraud, F, 1983) |
| " Nineteen patients had ocular manifestations of giant cell arteritis always from the onset, except for a fall in visual acuity; 26 relapses were observed in 18 patients, either during reduction of steroid dosage (21 cases) or after withdrawal (5 cases)." | 1.27 | [Prognosis of treated temporal arteritis. Retrospective study of 87 cases]. ( Alcalay, M; Becq-Giraudon, B; Boissonnot, L; Bontoux, D; Gil, R; Gouet, D; Le Berre, D; Lefevre, JP; Maréchaud, R; Risse, JF, 1986) |
| " A daily dosage of 75 to 100 mg would seem to provide a good compromise between the anti-inflammatory and haemolytic effects." | 1.27 | [Disulon in the treatment of Horton's disease. Experience with 20 patients]. ( Bonnetblanc, JM; Bordessoule, D; Liozon, F; Loustaud, V; Michel, JP; Vidal, E; Weinbreck, P, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (61.90) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yates, M | 1 |
| Loke, YK | 1 |
| Watts, RA | 1 |
| MacGregor, AJ | 1 |
| Ly, KH | 1 |
| Dalmay, F | 1 |
| Gondran, G | 1 |
| Palat, S | 1 |
| Bezanahary, H | 1 |
| Cypierre, A | 1 |
| Fauchais, AL | 1 |
| Liozon, E | 4 |
| Ly, K | 1 |
| Doury, P | 5 |
| Pattin, S | 4 |
| Eulry, F | 4 |
| Maurel, C | 2 |
| Masson, C | 2 |
| Tabaraud, F | 2 |
| Liozon, F | 4 |
| Vidal, E | 4 |
| Bonnetblanc, JM | 2 |
| Michel, JP | 2 |
| Bordessoule, D | 3 |
| Gasparini, M | 1 |
| Fabresse, FX | 1 |
| Celton, H | 1 |
| Larroque, P | 1 |
| Thabaut, A | 1 |
| Nesher, G | 1 |
| Sonnenblick, M | 1 |
| Boutros-Toni, F | 1 |
| Gaches, F | 1 |
| Loustaud-Ratti, V | 1 |
| Berdah, JF | 1 |
| Pesce, A | 1 |
| Taillan, B | 1 |
| Vinti, H | 1 |
| Rosenthal, E | 1 |
| Garnier, G | 1 |
| Cassuto, JP | 1 |
| Solau-Gervais, E | 1 |
| Flipo, RM | 1 |
| Lons, T | 1 |
| Richardet, JP | 1 |
| Machayekhi, JP | 1 |
| Dalbergue, B | 1 |
| Trinchet, JC | 1 |
| Demaziere, A | 1 |
| Gouet, D | 1 |
| Maréchaud, R | 1 |
| Le Berre, D | 1 |
| Alcalay, M | 1 |
| Becq-Giraudon, B | 1 |
| Boissonnot, L | 1 |
| Bontoux, D | 1 |
| Gil, R | 1 |
| Lefevre, JP | 1 |
| Risse, JF | 1 |
| Fourgnaud-Gaillard, S | 1 |
| Rousset, H | 1 |
| Weinbreck, P | 2 |
| Cransac, M | 1 |
| Boesen, P | 1 |
| Dideriksen, K | 1 |
| Stentoft, J | 1 |
| Jensen, MK | 1 |
| Reinitz, E | 1 |
| Aversa, A | 1 |
| Loustaud, V | 1 |
6 reviews available for dapsone and Giant Cell Arteritis
| Article | Year |
|---|---|
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dap | 2014 |
[Giant cell arteritis].
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Anti-Infective Agents; Biopsy; Blood Sedimentation; C-Re | 2008 |
[Therapy of polymyalgia rheumatica].
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anti-Inflammatory Agents; Benzodiazepines; Benzothiadiaz | 1984 |
Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients.
Topics: Aged; Aged, 80 and over; Dapsone; Female; Giant Cell Arteritis; Humans; Methotrexate; Prednisone | 1994 |
[Clinical course of Horton disease. Apropos of 42 cured patients].
Topics: Aged; Aged, 80 and over; Dapsone; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednison | 1994 |
[Agranulocytosis caused by dapsone. Apropos of 3 cases. Review of the literature].
Topics: Aged; Aged, 80 and over; Agranulocytosis; Dapsone; Female; Giant Cell Arteritis; Humans | 1988 |
15 other studies available for dapsone and Giant Cell Arteritis
| Article | Year |
|---|---|
Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patients.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Biopsy; Dapsone; Drug Hypersensitivity; Drug Toleran | 2016 |
[Treatment of Horton's disease and rhizomelic pseudopolyarthritis with dapsone. Preliminary results].
Topics: Aged; Dapsone; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica | 1983 |
[Dapsone in the treatment of Horton's disease].
Topics: Aged; Dapsone; Giant Cell Arteritis; Humans | 1983 |
[Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica].
Topics: Aged; Anemia, Hemolytic; Dapsone; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Iatrogeni | 1984 |
The use of dapsone in the treatment of giant cell arteritis and polymyalgia rheumatica.
Topics: Aged; Anti-Inflammatory Agents; Dapsone; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rhe | 1983 |
[Value of dapsone in the treatment of Horton's disease and rhizomelic pseudopolyarthritis].
Topics: Aged; Dapsone; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica; Prednisone | 1983 |
[Regressive trigeminal neuropathy under dapsone in temporal arteritis].
Topics: Aged; Dapsone; Female; Giant Cell Arteritis; Humans; Neuritis; Trigeminal Nerve | 1993 |
[Rhizomelic pseudopolyarthritis: diagnosis, course, treatment].
Topics: Age Factors; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; | 1999 |
[Granulomatous hepatitis caused by dapsone].
Topics: Adrenal Cortex Hormones; Aged; Chemical and Drug Induced Liver Injury; Dapsone; Drug Therapy, Combin | 1992 |
Dapsone in the long-term treatment of temporal arteritis.
Topics: Agranulocytosis; Dapsone; Giant Cell Arteritis; Humans | 1989 |
[Dapsone in rheumatology].
Topics: Arthritis, Rheumatoid; Dapsone; Giant Cell Arteritis; Humans; Polychondritis, Relapsing; Polymyalgia | 1986 |
[Prognosis of treated temporal arteritis. Retrospective study of 87 cases].
Topics: Aged; Chloroquine; Cyclophosphamide; Dapsone; Drug Therapy, Combination; Female; Giant Cell Arteriti | 1986 |
Dapsone in temporal arteritis and polymyalgia rheumatica.
Topics: Adult; Dapsone; Giant Cell Arteritis; Humans; Middle Aged; Polymyalgia Rheumatica | 1988 |
Long-term treatment of temporal arteritis with dapsone.
Topics: Aged; Dapsone; Giant Cell Arteritis; Humans; Male | 1988 |
[Disulon in the treatment of Horton's disease. Experience with 20 patients].
Topics: Aged; Aged, 80 and over; Dapsone; Drug Evaluation; Female; Giant Cell Arteritis; Humans; Male; Middl | 1986 |